We support pharmaceutical companies in the UK with brand launches
Accurately predicting the timeline for a new drug to appear on the GP system is crucial for effective planning of sales force and marketing activities during the drug launch. In addition ensure the brand listing is optimised within prescribing systems is crucial to success, We provide a comprehensive and reliable service to help ensure a smooth and efficient listing process.
Our services are designed to provide peace of mind for pharmaceutical companies looking to list a new brand on doctors’ prescribing systems. With our expertise and commitment to excellence, we strive to make the process as smooth and stress-free as possible.
Product Submission
to NHS BSA
dm+d and
drug tariff update
Clinical System Listings
Oberoi Workstreams
Mapping
Determine the predicted timelines for listing the drug in the GP system
Information Review
Review the product information prior to submission to the NHS Business Services Authority
NHS Business Services Authority
Liaise with the NHS Business Services Authority on behalf of the client
Audit
Conduct regular audits of clinical systems listings to ensure alignment with predicted timelines
GP System Listing Confirmation
Obtain visual confirmation of the listing in the GP system to provide brand and sales teams with full visibility
Clinical System Providers
Liaise with clinical system providers to understand key factors that may impact the timeline or display of the drug
Benefits
Facilitates prescribing, dispensing, and reimbursement of products into GP, hospital, and community pharmacy systems
Ensures timely entry into clinical decision and prescribing support software used across the UK, allowing for the integration of the new drug into clinical workflows
Enables the electronic prescription service, making it easier for clinicians to prescribe the new drug
Facilitates interoperability across UK Health Tech, leading to increased patient safety and improved healthcare outcomes
Client Feedback
“The Oberoi team worked with us at Theramex to ensure our new product was available to prescribe on GP clinical systems, across the UK, at the time of launch.
If you are launching a new product I would highly recommend working with Oberoi Consulting”
